While these observed improvements did not reach statistical significance, they are in accordance with the results of the randomized clinical trials ALFA-0701 [ 9 ] and MRC AML-15 [ 5 ].
← all excerpts
A Danish nationwide population-based cohort study on acute myeloid leukemia with RUNX1::RUNX1T1 - Real-world outcomes and clinicopathological characteristics.
1
—
—